UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Cuts Stock Position in Schrödinger, Inc. (NASDAQ:SDGR)

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC reduced its position in Schrödinger, Inc. (NASDAQ:SDGR) by 0.3% during the 3rd quarter, according to its most recent filing with the SEC. The firm owned 2,157,696 shares of the company’s stock after selling 5,742 shares during the quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC’s holdings in Schrödinger were worth $40,025,000 as of its most recent filing with the SEC.

A number of other large investors also recently bought and sold shares of the company. Nisa Investment Advisors LLC boosted its holdings in shares of Schrödinger by 145.3% in the second quarter. Nisa Investment Advisors LLC now owns 1,413 shares of the company’s stock valued at $27,000 after acquiring an additional 837 shares in the last quarter. GAMMA Investing LLC boosted its holdings in Schrödinger by 49.5% in the 2nd quarter. GAMMA Investing LLC now owns 2,124 shares of the company’s stock valued at $41,000 after purchasing an additional 703 shares in the last quarter. KBC Group NV increased its position in Schrödinger by 45.4% during the 3rd quarter. KBC Group NV now owns 2,508 shares of the company’s stock worth $47,000 after purchasing an additional 783 shares during the period. nVerses Capital LLC purchased a new position in shares of Schrödinger during the 2nd quarter worth approximately $66,000. Finally, Quest Partners LLC lifted its holdings in shares of Schrödinger by 1,005.6% in the 2nd quarter. Quest Partners LLC now owns 4,555 shares of the company’s stock valued at $88,000 after buying an additional 4,143 shares during the period. Hedge funds and other institutional investors own 79.05% of the company’s stock.

Schrödinger Stock Down 2.4 %

NASDAQ:SDGR opened at $21.95 on Wednesday. Schrödinger, Inc. has a 52-week low of $16.67 and a 52-week high of $38.00. The stock has a fifty day simple moving average of $18.91 and a 200-day simple moving average of $20.14. The company has a market capitalization of $1.60 billion, a PE ratio of -9.38 and a beta of 1.56.

Schrödinger (NASDAQ:SDGR) last announced its earnings results on Tuesday, November 12th. The company reported ($0.52) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.40) by ($0.12). The business had revenue of $35.30 million for the quarter, compared to analyst estimates of $41.25 million. Schrödinger had a negative return on equity of 35.77% and a negative net margin of 91.84%. The business’s revenue was down 17.1% on a year-over-year basis. During the same quarter in the previous year, the firm posted ($0.86) EPS. As a group, equities analysts anticipate that Schrödinger, Inc. will post -2.29 earnings per share for the current year.

Wall Street Analyst Weigh In

A number of research analysts recently weighed in on the company. Morgan Stanley dropped their price objective on Schrödinger from $43.00 to $30.00 and set an “equal weight” rating on the stock in a report on Wednesday, August 21st. BMO Capital Markets upped their price target on shares of Schrödinger from $25.00 to $28.00 and gave the stock an “outperform” rating in a research note on Wednesday, November 13th. Three research analysts have rated the stock with a hold rating, seven have given a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat.com, Schrödinger presently has an average rating of “Moderate Buy” and a consensus price target of $32.90.

Insider Activity at Schrödinger

In related news, insider Margaret Dugan sold 1,531 shares of the business’s stock in a transaction dated Tuesday, October 15th. The shares were sold at an average price of $17.78, for a total value of $27,221.18. Following the completion of the transaction, the insider now owns 13,469 shares of the company’s stock, valued at approximately $239,478.82. The trade was a 10.21 % decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. 8.60% of the stock is owned by corporate insiders.

Schrödinger Company Profile

Schrödinger, Inc, together with its subsidiaries, develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment is focused on licensing its software to transform molecular discovery for life sciences and materials science industries.